Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer ...

Moderna (MRNA) stock surged 7% this week following Oracle (ORCL) CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure cancer.

Larry Ellison, the billionaire founder of database behemoth Oracle, more and more resembles a villain out of a science ...

Larry Ellison of Oracle and also included Microsoft, NVIDIA and more. "A new American company that will invest $500 billion, at least, in AI infrastructure in the United States, creating over ...

At the launch of Stargate Project, Oracle's Ellison said that AI could assist in identifying the cancer fragments early ...

Oracle founder Larry Ellison said the massive artificial intelligence ... "And you can make that vaccine, that mRNA vaccine, you can make that robotically again using AI in about 48 hours." ...

Moderna shares are rising after Oracle’s Larry Ellison highlights AI’s role in ... and sequence cancer genes to create personalized mRNA vaccines. He claimed AI-driven automation could enable ...

Many of them fixated on remarks that billionaire Larry Ellison, founder and former CEO of Oracle and currently its chief technology ... Stargate could lead to the AI-facilitated production of mRNA ...

Billionaire Larry Ellison’s ... wishes,” Ziman said, adding, “Ellison is completely maneuvering.” Ellison’s Skydance declined to comment. Ellison’s Oracle spokeswoman and a Trump ...

Oracle Chairman Larry Ellison highlights AI's potential to enable ... Using AI-driven automation, such mRNA vaccines could be produced robotically within 48 hours, significantly accelerating ...